Inaugural Southern California Genitourinary Cancer Research Forum

Costa Mesa, CA US
March 1, 2024

Inaugural Southern California Genitourinary Cancer Research Forum Overview

A formalized process/platform does not exist for clinicians to share clinical trial portfolios amongst various institutions within specific regions. In addition, there is no systematic means for updating providers regarding advances in genitourinary cancers, which may positively affect patient outcomes. The rapidly changing landscape of treatment options for patients with genitourinary cancers makes it necessary for providers to discuss and collaborate in a multidisciplinary care setting to provide optimal care. 

This conference will focus on exploring clinical trials, cutting edge treatment options and help develop and facilitate collaborations to make advanced treatment options more accessible and widespread.

Forum Highlights

  • Updates from key studies in genitourinary (GU) cancers.
  • Discussions around available clinical trials in Southern California.
  • Networking with key opinion leaders in prostate, bladder, kidney and testicular cancer.

Target Audience

This educational program is directed towards medical oncologists, urologists, radiation oncologists with interests in genitourinary cancer and all other allied health care professionals interested in the subject matter.

Learning Objectives

  • Define clinical trial opportunities for patients with genitourinary cancers in the Southern California region.
  • Demonstrate understanding of best clinical practices for systemic therapy for genitourinary cancers.
  • Outline best clinical practices for radiation and surgery for genitourinary cancers.
  • Develop collaborations among investigators with interest in genitourinary cancers in Southern California.
  • Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).

JOIN US FOR THE
2024 Inaugural Southern California
Genitourinary Cancer Research Forum 
at the Avenue of the Arts | Costa Mesa, CA

Activity summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Inaugural Southern California Genitourinary Cancer Research Forum for a maximum of 4.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 4.00 Attendance
Activity opens: 
12/29/2023
Activity expires: 
05/08/2024
Event starts: 
03/01/2024 - 6:35am PST
Event ends: 
03/01/2024 - 3:00pm PST
Cost:
$1.00
Add to calendar: 

Avenue of the Arts Costa Mesa, a Tribute Portfolio Hotel
3350 Avenue of the Arts
Costa Mesa, CA 92626
United States

Discounted Event Parking:

- Self-Parking: $8 per Vehicle
- Valet Parking: $10 per Vehicle

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 4.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

DISCLOSURE INFORMATION: 

This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.

As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any ineligible company. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest, and an "ineligible company" as any entity producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Any potential conflicts relative to the previous disclosure have been resolved.

Written disclosure of all such relevant financial relationships will be provided in the activity handout and/or syllabus. Any potential conflicts relative to the previous disclosure have been resolved.

City of Hope further encourages faculty/authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.

The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Inaugural Southern California Genitourinary Cancer Research Forum for a maximum of 4.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 4.00 Attendance

Exhibiting/Sponsorship

City of Hope is pleased to offer the opportunity to exhibit and/or sponsor the Inaugural Southern California Genitourinary Cancer Research Forum, an ACCME accredited symposium addressing the advances in genitourinary cancers.

Exhibit space & sponsorship is available to companies interested in participating in this forum.

 

EXHIBITOR BOOTH/SPONSOR REGISTRATIONS CANNOT BE PROCESSED ONLINE.

Please contact the Department of Continuing Medical Education in order to receive more information, at cme@coh.org.

Acknowledgment of Commercial Support: Any and all grant support will be acknowledged at the forum via signage and will be listed in the forum materials.

 

Price

Cost:
$1.00
There are no more spaces available for this course.

REGISTRATION NOW CLOSED (NO ONSITE REGISTRATIONS ALLOWED) 

WE HOPE YOU CAN JOIN US NEXT YEAR! 

Registrant Type

Registration

Physician$0
Nurse/Other Allied Health Care Provider$0
City of Hope Physician/Staff$0
Student/Resident/Fellow$0
*Industry/Commercial Employee Attendee$3,000

Registration Fee: Registration fee includes all forum sessions, CME Credit, forum meals, and refreshment break.

Last day to register: February 26, 2024

Cancellation Policy: Refund requests must be submitted in writing and postmarked no later than February 12, 2024. A $50 processing fee will be applied for all refunds. Requests postmarked after Monday, February 12, 2024, will not be honored. All refunds will be processed 30 days after the meeting concludes. In the event of unforeseeable circumstances that lead to the cancellation by the forum organizers, all registration fees will be fully refunded.

For questions, contact the Department of Continuing Medical Education at cme@coh.org or 626-218-5622.

*Industry/Commercial Employee Attendee is defined as any individual employed by a for-profit, including biotech, financial and pharmaceutical.